Cardiac cycle efficiency during counterpulsation  by Gelsomino, Sandro & Romano, Salvatore Mario
Letters to the Editorsuperior to an operation requiring
a 2-day hospitalization from a socio-
economic standpoint.
Another advantage to this tech-
nique is that it can be performed as
part of a complete echo-endoscopic
mediastinal staging procedure (endo-
bronchial ultrasoundþ endoscopic ul-
trasound), which can now allow for
the evaluation and biopsy of all medi-
astinal lymph node stations during
a single outpatient endoscopic proce-
dure. Single-port thoracoscopy cannot
provide complete mediastinal staging,
therefore necessitating additional pro-
cedures in cases requiring it.
Moishe Liberman, MD, PhD
CHUM Endoscopic Tracheobronchial
and Oesophageal Center







We readwith great interest the recent
article by Onorati and colleagues,1
whose findings are in accordance with
our own data obtained in an animal
model arranged to investigate the ef-
fects of intra-aortic balloon pump
(IABP)/heart volume ratio modifica-
tion.2 We congratulate them for having
addressed such a controversial topic
and for shedding additional light on
the IABP weaning method. Indeed,
this publication underlines the superi-
ority of progressive volume variation
relative to the traditional rate reduction
method as a procedure for IABP wean-
ing, as we hypothesized on the basis of
the negative effects of reducing the
IABP/heart volume ratio, in terms of
both hemodynamic performance and
metabolic response.
Onorati andcolleagues1 used the car-
diac cycle efficiency (CCE), derivedThe Journalfrom the arterial pressure waveform,
as their measure of hemodynamic per-
formance. The CCE expresses the abil-
ity of the cardiovascular system to
maintain homeostasis at different en-
ergetic levels resulting from simulta-
neous interactions among pump
function (both mechanical and electri-
cal contributions), the arterial system,
venous return, and the pulmonary
circulation.3
We noticed, however, that patients
in both groups had high CCEs. The
value of the CCE is always less than
1, because part of energy is lost during
heart work and cannot be totally re-
covered (an increase in entropy).
This ‘‘efficiency’’—unlike the purely
mechanical performance, which is al-
ways between 0 and 1—can also ha-
ve in vivo negative values, and
this represents a compensatory mech-
anism to activate the support for the
body’s compartments that are not
working properly.3
Such high CCE values in the article
of Onorati and colleagues1 might be
attributable to underdamping or reso-
nance artifacts that frequently affect
blood pressure measurements in oper-
ating rooms and intensive care units
and cause severe overestimation of
systolic blood pressure and incorrect
estimation of hemodynamic parame-
ters when the pulse contour method
is used.4 It is well known that patients
undergoing cardiovascular surgery are
at high risk of artifacts caused by
underdamping because of high vascu-
lar stiffness, advanced age, and other
conditions.4 In addition, the dynamic
impedance is strongly influenced by
the balloon in patients with IABPs,
and as a result artifacts are very com-
mon, affecting the diastolic peak. In
our opinion, great attention must
therefore be paid to the accuracy of
the pressure signals received during
IABP weaning procedures.
It is also important to consider that
the damping coefficients of standard
transducer systems have been manu-
factured with the aim of obtaining
the highest level of detail availableof Thoracic and Cardiovascular Surgefrom the arterial wave signal while
maintaining the risk of underdamping
as low as possible for the whole
patient population, and not a specific
group of patients. Extra damping
must therefore be introduced to mini-
mize the distorting effects of the
measurement system’s tendency to
resonate. Nonetheless, the damping
coefficient obtained is frequently in-
sufficient, and resonance artifacts
may affect the morphology and am-
plitude of the recorded pressure
wave. Under these conditions, a dedi-
cated transducer manufactured for
limiting resonant effect is an useful
device, although interpretation of
the resulting waveform does require
some experience.5
We would appreciate comments
from Onorati and colleagues1 regard-
ing whether this issue was addressed
and how they proceeded to limit these
underdamping artifacts.
We are grateful to Onorati and col-
leagues1 for sharing their experience
and knowledge in this excellent study.
An elucidation and comment of the
point discussed here would be helpful
for a better understanding of the nu-
ances of IABP pathophysiology and
management in these patients.
Sandro Gelsomino, MD, PhD
Salvatore Mario Romano, PhD
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We are grateful to Drs Gelsomino
and Romano for their interest in our
article.1 They raise several important
issues related to the adequacy of in-
vestigating the cardiovascular system
bymeans of the pressure recording an-
alytical method (PRAM) and to the
methods used to attenuate the risk
of underdamping/resonance artifacts
in vivo, potentially responsible for an
incorrect measurement of hemody-
namic parameters.1,2
Dynamic response artifacts are often
observed in patients receiving periph-
eral monitoring based on pulse contour
analysis.3 In particular, underdamping
effects are frequently observed when-
ever the stiffness of the cardiovascular
system, including the apparatus for
pulse pressure ‘‘transduction,’’ is aug-
mented.3,4 Therefore, conditions such
as systemic arterial hypertension, se-
vere calcified ascending aorta, diffuse
atherosclerosis of the aortic arch,
systemic vasoconstriction, hypovole-
mic conditions, and a stiff trans-
duction system (related to the use of
numerous stopcocks, stiff tubes, and
arterial transduction catheters) all
contribute to increase the risk for
dynamic response artifacts.3,4
Although transducers ad hoc manu-
factured to avoid underdamping arti-
facts exist on the market,3 they were
not available at our institution at the
time of the study and therefore were
not used. Accordingly, our detection
system might have been unable to rec-
ognize and consequently ‘‘clean’’ pos-
sible dynamic artifacts.
However, as for any detection sys-
tem based on pulse contour analysis,
the recorded variables were validated890 The Journal of Thoracic and Cby an expert operator. For a correct in-
terpretation of any data, the PRAM
method undeniably requires a proper
recognition of the dicrotic notch
(which can be easily misrecognized
by the machine and in cases of
underdamping/resonance artifacts).
Therefore, back to Gelsomino and Ro-
mano’s question, no data were col-
lected in our study unless validated
by a fully trained operator. Therefore
whenever artifacts existed, the detect-
ing system was ‘‘restarted’’ to achieve
a correct recognition of the pulsewave,
thus collecting data only when the sys-
tem properly interpreted the pulse.
An additional troubleshooting ma-
neuver was to move to a different arte-
rial site to derive a ‘‘correct’’ pulse
wave (mainly the common femoral ar-
terial access, where artifacts were less
commonly encountered in our experi-
ence). Furthermore, the transduction
systemwas a priori optimized by using
only 1 stopcock and flexible tubing/ar-
terial catheters, and only 20F catheters
for radial transduction or 18F cathe-
ters for femoral transduction.
These problems were rarely encoun-
tered during the study because of the
setting and the peculiar hemodynamic
pattern of the enrolled population: Pa-
tients weaned from an intra-aortic bal-
loon pump (IABP) are usually
vasodilated (because of the IABPeffect
or the concomitant use of vasodilating
drugs); moreover, patients with severe
atherosclerotic aortic arch or thoracic
descending aorta did not undergo trans-
femoral IABP because of institutional
policies (and thus were not enrolled in
this study). Given the peculiar design
of the trial, based on the hemodynamic
monitoring and surveillance of a poten-
tial perioperative low cardiac output
state after weaning, all patients were
maintained at proper preload (central
venous pressure maintained at 8-12
mm Hg) and afterload states: thus,
conditions such as vasoconstriction
and hypovolemia, potentially favoring
underdamping/resonance artifacts,were
avoided. On the basis of this approach,
it can be easily recognized that theardiovascular Surgery c March 2013most common causes of underdamping
were prevented but overall rare in this
specific patient population.
In addition, wewant to underscore 3
major validation aspects of our study:
1. Before using PRAM, we per-
formed a ‘‘cross-check’’ validation
of data via a pilot study. We ana-
lyzed the reliability of hemody-
namic indices derived from
PRAM compared with those de-
rived by the traditional Swan–
Ganz thermodilution method. As
in other reports,5 this preliminary
study demonstrated a perfect
agreement between PRAM and
Swan–Ganz data, unless paroxys-
mal high-rate atrial fibrillation oc-
curred. However, a new onset of
high-rate atrial fibrillation did not
occur in our patients during the
weaning trial. Of note, a new onset
of high-rate atrial fibrillation at our
institution is considered a contrain-
dication to the progression of an
IABP-weaning trial.
2. Our trialwas designed to investigate
at 360 degrees the impact of the 2
weaning strategies on the entire car-
diovascular system. Accordingly,
hemodynamic and biochemical
indices were collected, such as tro-
ponin I and lactate, the former
showing the myocardial perfusion
and the latter showing the adequacy
of peripheral ‘‘oxygenation.’’
Again, peripheral lactate confirmed
the superiority of the ‘‘volume-
deflation’’ method versus the ‘‘rate-
reduction’’ strategy in terms of
peripheral perfusion.
3. Romagnoli and colleagues3 have
demonstrated that whenever under-
damping/resonance effects exist,
significant differences are recorded
betweenhemodynamic data derived
from ‘‘conventional’’ PRAM and
those derived from underdamping/
resonance-corrected PRAM by
means of specific transducers. As
we mentioned, these transducers
were not available at the time we
started the study. Furthermore, an
